Jadran - Galenski Laboratorij d.d.
Jadran - Galenski Laboratorij d.d., commonly known as JGL, is a prominent pharmaceutical company headquartered in Croatia (HR). Established in 1991, JGL has made significant strides in the healthcare sector, focusing on the development, production, and distribution of innovative pharmaceutical products. The company operates primarily in the European market, with a strong presence in various regions. JGL is renowned for its diverse portfolio, which includes prescription medications, over-the-counter products, and medical devices, particularly in the fields of otorhinolaryngology and dermatology. What sets JGL apart is its commitment to research and development, ensuring high-quality standards and unique formulations that cater to specific health needs. With a solid market position and numerous accolades, JGL continues to be a key player in the pharmaceutical industry, dedicated to improving patient outcomes and advancing healthcare solutions.
DitchCarbon Score
How does Jadran - Galenski Laboratorij d.d.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Jadran - Galenski Laboratorij d.d.'s score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Jadran - Galenski Laboratorij d.d.'s reported carbon emissions
In 2023, Jadran - Galenski Laboratorij d.d. reported a Scope 1 and 2 greenhouse gas (GHG) emissions intensity of approximately 0.000071 kg CO2e per unit of revenue, based on total revenue of about USD 231.6 million. This figure reflects the company's commitment to monitoring its carbon footprint, although specific absolute emissions data for the year is not disclosed. In 2022, the emissions intensity was slightly higher at about 0.000075 kg CO2e per unit of revenue, with total revenue of approximately USD 189.1 million. The trend shows a focus on reducing emissions relative to revenue, indicating a potential commitment to improving operational efficiency. For 2021, the emissions intensity was reported at about 0.000055 kg CO2e per unit of revenue, with total revenue around USD 159.8 million. This suggests a gradual improvement in emissions management over the years. Currently, Jadran - Galenski Laboratorij d.d. has not set specific reduction targets or initiatives, nor does it inherit emissions data from a parent company. The absence of formal climate pledges or SBTi targets indicates that while the company is tracking its emissions intensity, it may need to establish more concrete climate commitments to align with industry standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jadran - Galenski Laboratorij d.d. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
